ORIGINAL RESEARCH
Accepted on 12 May 2025
PSMD12 Promotes Hepatocellular Carcinoma Progression by Stabilizing CDK1
doi 10.3389/fimmu.2025.1581398
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Ubiquitination in Tumor Pathogenesis and Progression and its Therapeutic Potential
Ubiquitination in Tumor Pathogenesis and Progression and its Therapeutic Potential
997
Total downloads
4,969
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 01 May 2025
Ubiquitination and ALL: Identifying FBXO8 as a prognostic biomarker and therapeutic target
doi 10.3389/fimmu.2025.1554231
- 712 views
REVIEW
Published on 30 Apr 2025
Ubiquitination in lipid metabolism reprogramming: implications for pediatric solid tumors
doi 10.3389/fimmu.2025.1554311
- 842 views
ORIGINAL RESEARCH
Published on 25 Sep 2024
Higher frequency of peripheral blood CD103+CD8+ T cells with lower levels of PD-1 and TIGIT expression related to favorable outcomes in leukemia patients
doi 10.3389/fimmu.2024.1437726
- 1,630 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore